Glioblastoma is the most common and devastating primary brain tumor and the standard of care treatment includes maximal surgical resection followed by radiation and chemotherapy.
Retinal damage caused by ischemia, infection, or physical injury results in the degeneration or death of photoreceptor cells, as well as severe vision loss. No effective neuroprotective drugs are available in the clinic to restore damaged cells. Our research group has shown that intravenous transplantation of MSCs was effective in alleviating photoreceptor damage.